|
American
Society of Clinical Oncology (ASCO) Cancer
Genetics and Cancer Predisposition Testing Curriculum
Biesecker
BB, et al. Psychosocial factors predicting BRCA1/BRCA2
testing decisions in members of hereditary breast and
ovarian cancer families. Am J Med Genet. 2000;93:257-263. PubMed abstract
Burke
W, Daly M, Garber J et al. Recommendations for follow-up
care of individuals with an inherited predisposition
to cancer. II. BRCA1 and BRCA2 Cancer Genetics Studies
Consortium. JAMA. 1997;277:997-1003. (JAMA published
earlier than 1998 not available online). PubMed abstract
The
Cancer and Steroid Hormone Study of the Centers for
Disease Control and the National Institute of Child
and Human Development. The reduction in risk of ovarian
cancer associated with oral contraceptive use. N Engl J Med. 1987;316(11):650-655. PubMed abstract
Constantino
JP, et al. Validation studies for models projecting
the risk of invasive and total breast cancer incidence.
J Natl Cancer Inst. 1999 Sep 15;91(18):1541-8. PubMed
abstract
Di
Prospero LS, et al. Psychosocial issues following a
positive result of genetic testing for BRCA1 and BRCA2
mutations: findings from a focus group and a needs-assessment
survey. CMAJ. 2001;164:1005-1009. PubMed
abstract
Dorval
M, et al. Anticipated versus actual emotional reactions
to disclosure of results of genetic tests for cancer
susceptibility: findings from p53 and BRCA1 testing
programs. J Clin Oncol 2000;18:2135-2142. PubMed
abstract
Early
Breast Cancer Trialists' Collaborative Group. Tamoxifen
for early breast cancer: an overview of the randomised
trial. Lancet. 1998;351(9114);1451-1467. PubMed abstract
Easton
DF et al. Breast and ovarian cancer incidence in BRCA1-mutation
carriers. Am J Hum Genet. 1995;56:265-271. PubMed abstract
Feuer
EJ et al (1993): The lifetime risk of developing breast
cancer. JNCI 85: 892-897. PubMed abstract
Fisher
B, Costantino JP, Wickerham DL, et al. Tamoxifen for
prevention of breast cancer: report of the National
Surgical Adjuvant Breast and Bowel Project P-1 Study.
J Natl Cancer Inst. 1998;90(18):1371-1388. PubMed
abstract
|